Progress in the field of pancreatic endocrine tumors in Japan

Pancreas

Volumn 16, Issue 3, 1998, Pages 379-384

  Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Gut hormone; Pancreatic endocrine tumors; Radioimmunoassay

Indexed keywords

GASTRIN; PENTETREOTIDE IN 111;

ARTERIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; ENDOCRINE TUMOR; ENDOSCOPIC ECHOGRAPHY; GASTRIN BLOOD LEVEL; GASTRINOMA; INSULINOMA; JAPAN; MULTIPLE ENDOCRINE NEOPLASIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS TUMOR; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVIEW; SCINTIGRAPHY;

EID: 0031953782     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-199804000-00027     Document Type: Review

References (61)

1. Wilder RM, Allan FN, Power MH, et al. Carcinoma of the islands of the pancreas. Hyperinsulinism and hypoglycemia. JAMA 1927; 89:348-55.
2. Kadoo S, Nakamura H. I. Hyperinsulinemia. Grenzgebeit 1930;4: 1089-107.
3. Miyake M. Inselzellen Adenoma des Pancreas mit spontaner Hypoglykamie Tokyo Ishikai Zasshi 1933;47:815-21.
4. Kusunoki T, Munakata S. A patient with spontaneous hypoglycemia who was cured by extirpation of the islet cell tumor on the head of the pancreas. Nihon Shokaki Gakkai Zasshi 1936;35: 1021-9.
5. Zollinger RM, Ellison EH. Primary peptic ulcérations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955;142:709-28.
6. Gregory RA, Tracy JH, French JM, et al. Extraction of a gastrinlike substance from the pancreatic tumour in a case of ZollingerEllison syndrome. Lancet 1960;l:1045-8.
7. Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958;25: 374-80.
8. Bloom SR, Polak JM, Pearse AGE. Vasoactive intestinal peptide and watery diarrhea syndrome. Lancet 1973;2:14-6.
9. Unger RH, Eisentraut AM, Lochner JDV. Glucagon-producing tumors of the islets of Langerhans. J Clin Invest 1963;42:987-8.
10. Ganda OP, Weir GC, Soeldner JS, et al. "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med \911 ;296:963-l.
11. Kaneko H, Yanaihara N, Ito S, et al. Somatostatinoma of the duodenum. Cancer 1979;44:2273-9.
12. Kubota N, Matsumura H, Tsuchiya R, Yokoyama I. A case of ZoIlinger-EIlison syndrome. Gekachiryo 1964; 11:493-8.
13. Murata I, Hirono T, Maeda S. Zollinger-Ellison syndrome. Gekachiryo 1967;9:983-9.
14. Yoshinaga T, Okuno K, Shinji K, Tujii T, Nishikawa M. Pancreatic A cell tumor associated with severe diabetes mellitus. Nihon Rinsho 1965;23:2012-20.
15. Umeyama K, Nakayama K, Koike M, et al. A case of islet cell tumor associated with chronic diarrhea. Nihon Rinsho 1967;25: 337-47.
16. Fujiya H, Kawao A, Yanaibara N, et al. Malignant insulinogastrino-somatostatinoma. Harm Clin 1978;26:591-3.
17. Berson SA, Yallow RS. Plasma insulin in health and disease. Am J Med 1961;31:874-81.
18. Frawley TF, Pensuwan S. Hypoglycemia: tolbutamide and leucine tests in insulinoma. Med din North Am 1968:52:283-94.
19. Turner RC, Heding LG. Plasma proinsulin, C-peptide and insulin in diagnostic suppression tests for insulinomas. Diabetologia 1977; 13:571-7.
20. Marks V, Samols E. Glucagon test for insulinoma: a chemical study in 25 cases. J Clin Palhol 1968;21:346-52.
21. Hirata Y, Ishizu H, Ouchi N, et al. Insulin autoimmunity in a case with spontaneous hypoglycemia. Tohnyohbyo 1970;13:3I2-20.
22. Imamura M, Hattori Y, Nishida O, et al. Unresponsiveness of insulinoma cells to secretin-significance of secretin test in patients with insulinoma. Pancreas 1990:5:467-73.
23. Yasunami Y, Funakoshi A, Ono J, Miyazaki K, Jimi A, Konomi K. In vitro study of cultured human insulinoma cells: evidence of abnormal sensitivity to glucose. J Clin Endocrinol Metab 1987; 65:110-5.
24. Seino Y, Yamamoto T, Inoue K, et al. Abnormal facultative glucose transporter gene expression in human islets cell tumors: the cause of increased sensitivity of insulinoma to glucose? J Clin Endocrinol Melabol 1993;76:75-7.
25. Kaplan EL, Rubenstein AH, Evans R, et al. Calcium infusion. A new provocative test for insulinoma. Ann Surg I979;190:501-7.
26. Kato M, Imamura M, Okada N, et al. Effects of secretin on glucose stimulated insulin release from MIN6 cells. Biomed Res 1994;15: 361-2.
27. Okamoto H. Rig and reg: novel genes activated in insulinomas and in regenerating islets. Excerpta Medico Congress Series 1989;5562.
28. Kariya Y, Kato K, Hayashizaki Y, Himeno S, Tarui S, Matsubara K. Expression of human gastrin gene in normal and gastrinoma tissues. Gene 1986:50:345-52.
29. Isenberg JL, Walsh JH, Passaro E. Unusual effect of secretin in a patient with suspected Zollinger-Ellison syndrome. Gastroenterology 1972;62:626-31.
30. Imamura M, Adachi H, Takahashi K, et al. Gastrin release from gastrinoma cells stimulated with secretin. Dig Dis Sei 1982;27: 1136-9.
31. Chiba T, Yamatani T, Yamaguchi A, et al. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome Gastroenterology 1989;96:1439-44.
32. Imamura M, Takahashi K, Adachi H, et al. Usefulness of selective arterial secretin injection test for localization of gastrinoma in the Zollinger-Ellison syndrome. Ann Surg 1987:205:230-9.
33. Doppman JL, Miller DL, Chang R, et al. Insulinomas: localization with selective intraarterial injection of calcium. Radiology 1991; 178:237-41.
34. Imamura M, Tobe T. Localization of pancreatic endocrine tumors with arteriography, percutaneous transhepatic portal venous samplings, and selective arterial secretin injection test. Diag Imag Abd I990;10:865-71.
35. Bakker WH, Albert R, Bruns C, et al. ["'In-DTPA-D-PheJoctreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabelling and in vitro validation. Life Sei 1991;49:1583-9I.
36. Yamamoto K, Ishii Y, Furutachi M, et al. Clinical study (phase III) of '"in-DTPA-D-Phe-octreotide for diagnosis of gut hormone producing tumor. Kakiiigaku 1995;32:I269-80.
37. Imamura M, Takahashi K, Isobe Y, Hattori Y, Satomura K, Tobe T. Curative resection of multiple gastrinomas aided by selective arterial secretin election test and intraoperative secretin test. Ann Surg 1989;210:710-8.
38. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodénums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990;322: 723-7.
39. Imamura M, Kanda Y, Takahashi K, et al. Clinicopathological characteristics of duodenal microgastrinomas. World J Surg 1991; 16:703-10.
40. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997:276:404-7.
41. Nakamura T, Sasano N, Kuroda S, eds. Pancreas endocrine tumor. Tokyo: Igakutosho Press, 1983.
42. Soga J, Yakuwa Y. Pancreatic endocrinomas: a statistical analysis of 1,857 cases. J Hepat Bil Pancr Surg 1994;l:522-9.
43. Harris S. Hyperinsulinism and dysinsulinism. JAMA 1924;83:729-33.
44. Howland G, Campbell WR, Maltby ET, et al. Dysinsulinism. Convulsions and coma due to islet cell tumor of the pancreas, with operation and cure. JAMA 1929;93:674-9.
45. Whipple AO. The surgical therapy of hyperinsulinism. J Int Chir 1938:3:237-76.
46. Fajans SS, Conn JW. An intravenous tolbutamide test as an adjunct in the diagnosis of functioning pancreatic islet cell adenomas. J Lab Clin Med 1959:54:811-2.
47. Marks V. Response to glucagon by subjects with hyperinsulinism from islet cell tumors. Br Med J 1960;39:1539-40.
48. Yallow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest 1960;89: II57-75.
49. Steiner DF, Oyer PE. The biosynthesis of insulin and a provable precursor of insulin by a human islet cell adenoma. Proc NatlAcad Sei USA 1967;18:473-80.
50. Rubenstein AH, Clark JL, Melani F, et al. Secretion of proinsulin C-peptide by pancreatic B cell and its circulation in blood. Nature 1969;224:697-9.
51. Ingemansson S, Lunderquist I, et al. Portal and pancreatic vein catheterization with radioimmunologic determination of insulin. Surg Gynecol Obstet 1975;141:705-11.
52. Oberhelman HA Jr, Nelson TS, Dragstedt LR. Peptic ulcer associated with tumors of the pancreas. Arch Surg 1958;77:402-15.
53. McGuigan JE, Trudeau WL. Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety. N Engl J Med 1968;278: 1308-13.
54. Ingemansson S, Larsson L, Lunderquist A, Stadil F. Pancreatic vein catheterization with gastrin assay in normal patients and in patients with the Zollinger-Ellison syndrome. Am J Surg 1977:134: 558-63.
55. Howard TJ, Sawicki MP, Stabile BE, et al. Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am J Surg 1993:30:489-92.
56. Stabile BE, Morrow DJ, Passaro E Jr. The gastrinoma triangle: operative implications. Am J Surg 1984;147:25-31.
57. Thompson NW, Vinik AI, Eckhauser FE. Microgastrinomas of the duodenum: a cause of failed operations for the Zollinger-Ellison syndrome. Ann Surg 19S9;209:396-464.
58. Frucht H, Norton JA, London JF, et al. Detection of duodenal gastrinomas by operative endoscopie transillumination: a prospective study. Gastroenterology 1990;99:1622-7.
59. Parley DR, Vanheerden JA, Grant CS, et al. The Zollinger-Ellison syndrome: a collective surgical experience. Ann Snrg 1992;215: 561-70.
60. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome: results of a 10-year prospective study. Ann Surg 1992;215:8-18.
61. Howard TJ, Zinner NU, Stabile BE, Passaro E Jr. Gastrinoma excision for cure: a prospective analysis. Ann Surg 1990;211:9-14.